Who Owns Innate Pharma S.A. Stock?
NASDAQ: IPHAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 0.35%
- Held by insiders
- 1.40%
- Institutional holders
- 11
- Institutions 0.4%
- Insiders 1.4%
- Public and other 98.2%
Who owns Innate Pharma S.A. stock?
Institutional investors own about 0.4% of Innate Pharma S.A.'s shares, spread across 11 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 1.40% of IPHA.
The largest institutional holders are Lion Point Capital, LP (0.07%), Morgan Stanley (0.04%) and Smartharvest Portfolios, LLC (0.02%). Together, the top 10 institutions control 0.2% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their IPHA positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of IPHA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Lion Point Capital, LP | 81.15K | 0.07% | 0.0% |
| Morgan Stanley | 43.52K | 0.04% | 0.0% |
| Smartharvest Portfolios, LLC | 23.75K | 0.02% | +100.0% |
| Xtx Topco Ltd | 15.13K | 0.01% | +100.0% |
| Citadel Advisors Llc | 12.44K | 0.01% | +100.0% |
| Jane Street Group, LLC | 10.31K | 0.01% | -76.2% |
| Rhumbline Advisers | 4.72K | 0.00% | -0.3% |
| UBS Group AG | 1.36K | 0.00% | +58.3% |
| Farther Finance Advisors, Llc | 21 | 0.00% | +110.0% |
| Gamma Investing LLC | 9 | 0.00% | -96.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of IPHA
| Fund | Shares | % Held |
|---|---|---|
| ETF Series Solutions-Range Cancer Therapeutics ETF | 72.69K | 0.08% |
Frequently asked questions
Who is the largest shareholder of Innate Pharma S.A.?
Lion Point Capital, LP is the largest institutional shareholder of IPHA, owning 0.07% of shares outstanding (81.15K shares) as of its latest 13F filing.
What percentage of Innate Pharma S.A. is owned by institutions?
Institutions own about 0.4% of IPHA shares and 0.4% of the public float.
How much of Innate Pharma S.A. do insiders own?
Insiders, such as officers and directors, own about 1.40% of IPHA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.